Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology
Please note that COPYRIGHT in the paper is owned by the British Association for Psychopharmacology (BAP). SINGLE ISSUE USE ONLY (and printing) for PERSONAL RESEARCH ONLY is acceptable. Information on where to apply for reprints and supplements is included below.
Co-Authors: Thomas R E Barnes and the Consensus Group
File size: 422 Kb
Contact: Thomas RE Barnes
Address: Centre for Mental Health, Imperial College, Charing Cross Campus, London W6 8RP, UK